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Abstract
Background: The incidence of rectovaginal fistula in women with Crohn’s disease has been reported to be 3–10 %.
Although rectovaginal fistulas can be managed medically and surgically, they have high rates of recurrence and
complications. Rectal stenosis is another condition that occurs due to perianal Crohn’s disease. A novel, minimally
invasive procedure, dual-port laparoscopic abdominoperineal resection using a multichannel port, has been shown
effective in patients with lower rectal cancer and patients with medically uncontrolled ulcerative colitis. This report
describes the use of the same method for two patients with Crohn’s disease-related rectovaginal fistula and rectal
stenosis.
Case presentation: The first patient, a 22-year-old woman, was diagnosed with rectovaginal fistula and rectal
stenosis due to perianal Crohn’s disease 2 years earlier. Induction therapy with infliximab and endoscopic balloon
dilatation did not improve her symptoms. The second patient, a 33-year-old woman, was also diagnosed with
rectovaginal fistula and rectal stenosis due to perianal Crohn’s disease, and medical treatment was also
unsuccessful. Both patients underwent dual-port laparoscopic abdominoperineal resection using a multichannel
port, with no perioperative and postoperative complications.
Conclusion: These findings show that this reduced port method can be used to successfully treat patients with
Crohn’s disease-associated rectovaginal fistula and rectal stenosis.
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Background
Fistulas are abnormal tracts arising from mucosal ulcera-
tions in the gastrointestinal tract that have progressed to
penetrate other structures [1]. The cumulative incidence
of fistulas in patients with Crohn’s disease (CD) has been
reported to be 33 % after 10 years and 50 % after
20 years, with 83 % of all fistula episodes requiring sur-
gery [2]. The incidence of rectovaginal fistulas (RVF) in
women with CD has been reported to be approximately
3–10 %. Although medical and surgical management
techniques have been described, these fistulas are diffi-
cult to manage because of their high rates of recurrence
and complications. In addition to RVF, women with CD
can also experience rectal stenosis, a major complication
that is also difficult to manage [3].
We have described the successful use of laparoscopic-
ally assisted anterior resection, using a single incision
and one additional port, for patients with rectal cancer
[4]. Based on this technique, we have developed a novel,
minimally invasive procedure, dual-port laparoscopic
abdominoperineal resection using a multichannel port,
and shown its effectiveness in patients with lower rectal
cancer and patients with medically uncontrolled ulcera-
tive colitis [5, 6]. This report documents the use of the




A 22-year old woman was diagnosed with colonic CD
6 years earlier. For 4 years, she experienced fluctuating
disease, with periods of remission and recurrence.
She was initially treated with maximal doses of 5-
aminosalicylate (5-ASA), and corticosteroids, but later
switched doses to azathioprine. Two years earlier, she
started to pass gas from her vagina, and she was
diagnosed with RVF due to CD. She was started on in-
duction therapy using infliximab, but her symptoms did
not improve. She also had a 2-year history of intestinal
obstruction due to CD-associated rectal stenosis. She
underwent endoscopic balloon dilatation to treat the
stenosis, but experienced no improvement. Because of
her inability to take nutrition through her intestinal
tract, she was started on total parenteral nutrition. She
consulted our department for the treatment of RVF and
repeat intestinal obstruction. A lower gastrointestinal
series showed the disappearance of haustra, along with
stenosis in the transverse and descending colon (Fig. 1a),
rectal stenosis and RVF (Fig. 1b). Dual-port laparoscopic
abdominoperineal resection, from the transverse colon
near the splenic flexure to the rectum, was performed.
The resected specimen showed both the RVF and rectal
stenosis (Fig. 2). The patient experienced no periopera-
tive or postoperative complications. She was discharged
14 days after surgery and has not experienced any recur-
rence of CD for 3 years.
A 33-year old woman was diagnosed with small intes-
tinal and colonic CD 14 years earlier. Six years ago, she
underwent ileocecal resection for stenosis of the ileum.
After surgery, she was started on infliximab but had to
discontinue treatment because of the side effects of that
drug. Three years ago, she started to pass gas from her
vagina, and she was diagnosed with RVF due to CD.
Medical therapy was unsuccessful, and she consulted
our department. A preoperative lower gastrointestinal
series showed the RVF, along with stenosis and the dis-
appearance of haustra in the transverse and descending
colon. She underwent the same operation as the first pa-
tient, with the same extent of resection. Pathological
examination showed a fistula from the rectum to the
vagina and stenosis from the transverse colon to the
rectum. She did not experience any perioperative or
Fig. 1 Preoperative lower gastrointestinal series of patient 1, showing stenosis and the disappearance of haustra in the transverse and
descending colon (white arrow in a) and the rectovaginal fistula (black circle in b)
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postoperative complications. She was discharged 15 days
after surgery and has not experienced recurrence of CD
for 4 years.
Operative procedures
A multichannel port was inserted through a 25-mm skin
incision in the right or left lower quadrant at the colos-
tomy site. The colostomy site was determined by the
preoperative marking, regardless of the surgical proced-
ure. The choice of multichannel port site was based on
the length of colon to be resected. An additional 5-mm
trocar for the left hand was inserted at the umbilicus
(Fig. 3). The surgeon and the assistant were positioned
on the patient’s right side (Fig. 4). For anterior dissec-
tion, the uterus was suspended by two stitches of 3–0
monofilament thread penetrating the left and right lower
abdomen near the pubic bone. The assistant retracted
the rectosigmoid ventrally using a curved grasper, and
the peritoneum was incised using an ultrasonic coagula-
tion incision device from the level of the sacral promon-
tory to the base of the inferior mesenteric artery. After
identification of the left ureter, the vascular pedicle was
lifted vertically by the assistant. The inferior mesenteric
artery was isolated and ligated 1 cm distal to the aorta.
The inferior mesenteric vein was also ligated. Pelvic dis-
section was performed along the presacral avascular
plane down to the pelvic floor and the top of the anal
canal. The rectum was completely mobilized to the level
of the levator ani muscle. The oral side of the intestine,
which was free of the mucosal disorder due to CD, was
cut off. Perineal dissection was performed circumferen-
tially to the pelvic cavity. The specimen was retrieved
through the perineal wound. A drain was placed from
the umbilicus into the pelvic bottom, and a colostomy
was fashioned at the site of the multichannel port
(Fig. 5).
Discussion
This study reports the performance of dual-port laparo-
scopic abdominoperineal resection using a multiple port
method. Neither patient experienced any perioperative
or postoperative complications. In contrast, the rates of
complications were reported to be much higher in pa-
tients with CD-related RVF who underwent conven-
tional proctectomy, with 35 % experiencing delayed
perineal wound healing, 17 % having intra-abdominal
sepsis, and 15 % experiencing stomal complications [7].
Another series reported delayed or failed perineal wound
healing in almost 50 % of patients [8]. The novel, min-
imally invasive procedure described here, dual-port
Fig. 2 View of the resected specimen from patient 2, showing a fistula from the rectum to the vagina (black arrow)
Fig. 3 Insertion of a multichannel port at the colostomy site
through a 25-mm skin incision in the right lower quadrant. A 5-mm
trocar was inserted via the umbilicus
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laparoscopic abdominoperineal resection using a mul-
tiple port, has been found effective in patients with
lower rectal cancer [5] and in patients with medically
uncontrolled ulcerative colitis [6]. This procedure was
completed successfully in all patients, without any
intraoperative complications, and all postoperative out-
comes were satisfactory.
This report describes our use of this surgical method
in two patients with CD-related RVF and rectal stenosis.
The abdominal cavity was approached using two
small incisions, with a multichannel port placed at
the colostomy site through a 25-mm skin incision in
the lower quadrant and a 5-mm trocar inserted via
the umbilicus for postoperative placement of a drain-
age tube. Neither patient experienced any intraopera-
tive or postoperative complications. We recently
reported that the postoperative neutrophil count was
lower after SLIS +1 port laparoscopy-assisted than
after conventional laparoscopy-assisted anterior resec-
tion for rectal cancer [4]. Furthermore, the former
group experienced a significant difference in body
temperature on postoperative day 1, indicating a
lower degree of inflammation. Our findings suggest
that this procedure, involving small incisions and
minimal invasiveness, may reduce the risk of compli-
cations and benefit not only patients with rectal
cancer and ulcerative colitis but also patients with
CD-related RVF and rectal stenosis.
CD is the second most common cause of RVF after
obstetrical trauma. The incidence of RVF in women with
CD is approximately 3–10 %. RVF may cause significant
clinical distress and social embarrassment. RVFs are ex-
tremely difficult to close medically [9], often leaving sur-
gery as the only option [10]. Medical treatments have
included antibiotics, corticosteroids, and immunosup-
pressants, but these agents are associated with low rates
of long-term symptom control and unacceptably
high rates of recurrence [11]. Infliximab, a monoclonal
Fig. 4 Positioning of the surgeon and assistant on the patient’s right side
Fig. 5 Creation of a colostomy at the site of the multichannel port
and placement of the drain through the umbilicus
Matsuzawa et al. Surgical Case Reports  (2016) 2:83 Page 4 of 6
antibody to tumor necrosis-α (TNF-α), is a major ad-
vance in the treatment of fistulizing CD disease and has
completely altered treatment strategies for perianal dis-
ease [12]. However, analysis of the results of the AC-
CENT II (A CD Clinical trial Evaluating infliximab in a
New long-term Treatment regimen in patients with fis-
tulizing CD) trial found that 56 % of patients on main-
tenance therapy with infliximab experienced RVF
recurrence [10]. Another study showed that response to
infliximab differed among patients with different types
of CD fistula [13]. The closure rate after 4 to 6 weeks of
treatment was 76 % for all external CD fistulas, but only
14 % for CD-associated RVF [13].
Patients who cannot be managed medically or are re-
sistant or intolerant to infliximab can be managed surgi-
cally. Proctectomy was performed initially because of the
high recurrence rate of CD-related RVF and difficulties
treating rectal stenosis. To date, there have been no pro-
spective, randomized, controlled trials assessing methods
for the surgical correction of CD-related RVF [14].
Transvaginal, perineal, and transanal approaches, with
or without transabdominal mobilization, can be used for
local repair. Fecal diversion remains a problem, but
protecting the fistula repair with a diverting stoma was
reported to improve healing and reduce recurrence [15].
However, even with a diverting stoma, the cure rate
remains less than satisfactory. The rates of recurrence of
CD-related RVF have been reported to range from 25 to
50 %, higher than the recurrence rates of other CD fistulas
[16–20]. Furthermore, most studies have considered only
short-term outcomes. For example, of 12 patients with
CD-related RVF who underwent local repairs, 7 (58 %)
showed recurrence [16]. Proctectomy is still considered
the only radical cure for Crohn’s-related RVF.
Both patients in this report presented with RVF and
rectal stenosis, with the latter causing repeat intestinal
obstruction. Rectal strictures due to CD are as difficult
to treat as RVF. For example, 66 % of patients with
perianal CD and rectal strictures required a permanent
stoma, with multivariate analysis showing that rectal
stricture was independently predictive of the need for a
permanent stoma [3].
This report has certain limitations. First, both patients
had low degrees of adhesion, allowing conventional lap-
aroscopic surgery. Second, this operation required high
operative skill of the entire surgical team. The surgeon
and team in this study had experience with over 500
laparoscopic colorectal resection procedures, including
reduced port surgery for colorectal diseases including
colorectal cancer.
Conclusions
CD-related RVF and rectal stenosis are difficult to man-
age medically and surgically. Dual-port laparoscopic
abdominoperineal resection using a multichannel port,
when performed by experienced surgeons, may be useful
for selected patients with these conditions.
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